Quince Therapeutics
QNCX
QNCX
70 hedge funds and large institutions have $26M invested in Quince Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 26
55% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 31
74% less capital invested
Capital invested by funds: $99.5M → $26M (-$73.5M)
Holders
70
Holding in Top 10
1
Calls
$1.12M
Puts
$727K
Top Buyers
| 1 | +$620K | |
| 2 | +$620K | |
| 3 | +$393K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$378K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$289K |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$2.64M | |
| 3 | -$2M | |
| 4 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$1.78M |
| 5 |
SC
Sculptor Capital
New York
|
-$1.39M |